FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
If the FDA's decision on Saroglitazar by Zydus Therapeutics in 2026 is a full approval or an accelerated approval, the answer is Yes.
What's your call?
Nobody has called this yet. Yours could be the first. Voting closes Jan 1.
Be the first to vote
Question and outcome: Kalshi. CallItPoll is not affiliated with Kalshi and runs no betting or trading.